REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 220 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $34,733,082 | -5.3% | 340,654 | -15.6% | 0.01% | -10.0% |
Q1 2023 | $36,691,311 | +971.9% | 403,556 | +347.9% | 0.01% | +900.0% |
Q4 2022 | $3,423,051 | +402.7% | 90,104 | +232.4% | 0.00% | – |
Q3 2022 | $681,000 | -16.3% | 27,107 | +1.2% | 0.00% | – |
Q2 2022 | $814,000 | -55.7% | 26,777 | -52.3% | 0.00% | – |
Q1 2022 | $1,839,000 | -96.9% | 56,112 | -97.5% | 0.00% | -100.0% |
Q4 2021 | $60,134,000 | -82.6% | 2,280,409 | -33.7% | 0.01% | -84.1% |
Q3 2021 | $345,978,000 | -13.0% | 3,438,804 | +22.4% | 0.09% | -10.2% |
Q2 2021 | $397,659,000 | +94.0% | 2,809,716 | +36.6% | 0.10% | +78.2% |
Q1 2021 | $205,019,000 | -6.8% | 2,056,360 | +15.6% | 0.06% | -14.1% |
Q4 2020 | $219,979,000 | +301.3% | 1,779,475 | +216.3% | 0.06% | +236.8% |
Q3 2020 | $54,812,000 | +560.6% | 562,631 | +958.0% | 0.02% | +533.3% |
Q2 2020 | $8,297,000 | +3491.8% | 53,178 | +3234.0% | 0.00% | – |
Q1 2020 | $231,000 | -97.8% | 1,595 | -96.9% | 0.00% | -100.0% |
Q4 2019 | $10,618,000 | +500.2% | 51,937 | +177.0% | 0.00% | – |
Q2 2019 | $1,769,000 | +11.5% | 18,750 | +1.0% | 0.00% | -100.0% |
Q1 2019 | $1,586,000 | +560.8% | 18,558 | +333.4% | 0.00% | – |
Q4 2018 | $240,000 | – | 4,282 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |